Julie D.  Klapstein net worth and biography

Julie Klapstein Biography and Net Worth

Director of Claritev
Julie Klapstein was the founding Chief Executive Officer of Availity, LLC, a health information network optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. Ms. Klapstein served as Availity’s Chief Executive Officer and board member from 2001 to 2011. She also served as the interim Chief Executive Officer at Medical Reimbursements of America, Inc., a private company, from February 2017 to June 2017. Ms. Klapstein has more than 30 years of experience in the healthcare information technology industry including executive roles at healthcare companies including Phycom, Sunquest Information Systems, SMS’ Turnkey Systems Division and GTE Health Systems. Her early career with AT&T Information Systems also focused on the healthcare industry. Ms. Klapstein currently serves on the boards of: Amedisys, (NASDAQ:AMED) on the Quality and Governance committees and chair of the Compensation committee; NextGen Healthcare (NASDAQ:NXGN) on the Audit and Compensation committees; Oak Street Health (NYSE:OSH) on the Compliance committee and chair of the Compensation committee; and Revcore, a private company on the board of directors. Ms. Klapstein was previously a director for two additional public companies and multiple private companies.

What is Julie D. Klapstein's net worth?

The estimated net worth of Julie D. Klapstein is at least $29.22 thousand as of August 20th, 2021. Ms. Klapstein owns 752 shares of Claritev stock worth more than $29,215 as of December 4th. This net worth evaluation does not reflect any other assets that Ms. Klapstein may own. Learn More about Julie D. Klapstein's net worth.

How do I contact Julie D. Klapstein?

The corporate mailing address for Ms. Klapstein and other Claritev executives is , , . Claritev can also be reached via phone at 1-800-677-1098 and via email at [email protected]. Learn More on Julie D. Klapstein's contact information.

Has Julie D. Klapstein been buying or selling shares of Claritev?

Julie D. Klapstein has not been actively trading shares of Claritev during the past quarter. Most recently, on Friday, August 20th, Julie D. Klapstein bought 300 shares of Claritev stock. The stock was acquired at an average cost of $240.00 per share, with a total value of $72,000.00. Following the completion of the transaction, the director now directly owns 752 shares of the company's stock, valued at $180,480. Learn More on Julie D. Klapstein's trading history.

Who are Claritev's active insiders?

Claritev's insider roster includes Glenn August (Director), Anthony Colaluca, Jr (Director), Travis Dalton (President, CEO), Paul Galant (Insider), Douglas Garis (CFO), James Head (CFO), Julie Klapstein (Director), Michael Klein (Director), and William Mintz (SVP, Corporate Affairs & Strategy). Learn More on Claritev's active insiders.

Are insiders buying or selling shares of Claritev?

During the last twelve months, Claritev insiders bought shares 5 times. They purchased a total of 17,347 shares worth more than $710,937.70. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 1,500,000 shares worth more than $73,005,000.00. The most recent insider tranaction occured on November, 20th when CEO Travis Dalton bought 5,290 shares worth more than $249,846.70. Insiders at Claritev own 8.0% of the company. Learn More about insider trades at Claritev.

Information on this page was last updated on 11/20/2025.

Julie D. Klapstein Insider Trading History at Claritev

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2021Buy300$240.00$72,000.00752View SEC Filing Icon  
See Full Table

Julie D. Klapstein Buying and Selling Activity at Claritev

This chart shows Julie D Klapstein's buying and selling at Claritev by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Claritev Company Overview

Claritev logo
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Read More

Today's Range

Now: $36.77
Low: $36.45
High: $40.51

50 Day Range

MA: $54.97
Low: $36.77
High: $71.36

2 Week Range

Now: $36.77
Low: $5.61
High: $74.07

Volume

199,937 shs

Average Volume

263,456 shs

Market Capitalization

$607.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52